Tuesday newspaper round-up: OpenAI, GSK, Sam Bankman-Fried
By Michele Maatouk
Date: Tuesday 09 Jun 2026
(Sharecast News) - OpenAI has filed confidentially to go public on the US stock market, according to a company blogpost published on Monday. The artificial intelligence giant's debut on Wall Street is expected to be one of the most highly valued listings in market history with a valuation at more than $850bn. "We recently submitted a confidential S-1. We expect it to leak so we're just announcing it," the company's post reads. "We have not decided on timing yet; it may be a while because there are things we want to do that are likely easier as a private company. But it's a complicated set of tradeoffs and this gives us the option to go public sooner if that ends up being best." - Guardian
The US added Chinese e-commerce company Alibaba, internet search provider Baidu and automaker BYD to a list of companies it believes are aiding Beijing's military, in a move that could inflame tensions between the countries. The long-awaited update released on Monday supersedes a list from early 2025, and comes less than a month after Donald Trump met China's Xi Jinping on a visit to Beijing, where the two leaders maintained a delicate trade war truce. - Guardian
The Bank of England is pushing Elon Musk's X to crack down on deepfake adverts showing Andrew Bailey fighting Nigel Farage. A raft of AI-generated adverts have sprung up on the social media platform in recent days falsely showing the Bank of England governor in conflict with the Reform UK leader on the set of BBC's Question Time. - Telegraph
Families are demanding refunds from British tourist attractions after Rachel Reeves unveiled new discounts on summer tickets. Tourism businesses have warned that the Chancellor's decision to cut VAT on tickets for popular family destinations this summer has sparked chaos, as tens of thousands of customers seek to get their money back to take advantage of the new lower prices. - Telegraph
GSK has struck a £45 million deal focused on discovering new liver fibrosis drugs with a biotech company spun out of University College London The FTSE 100 company and Engitix, which is based in the White City life sciences cluster in west London, will collaborate in early-stage research on seeking to reverse the condition. - The Times
Sam Bankman-Fried, the 34-year-old founder of the cryptocurrency exchange FTX, who is serving a 25-year prison sentence for fraud and conspiracy, has applied for a pardon from President Trump. The website of the Office of the Pardon Attorney of the Department of Justice lists the request by Bankman-Fried and says its status is "pending". This means a clemency case has been opened and the petition is under review. - The Times
Email this article to a friend
or share it with one of these popular networks:
You are here: news
10 Lower Thames St,
London EC3R 6EN